SEARCH HEALTH CONDITIONS BY ALPHABETS
Paroxysmal Atrial Tachycardia
Medications for Paroxysmal Supraventricular Tachycardia
Other titles: Paroxysmal Atrial Tachycardia
About Paroxysmal Supraventricular Tachycardia: Paroxysmal supraventricular tachycardia (PSVT) is episodes of rapid heart rate which begin in a part of the heart over the ventricles. "Paroxysmal" way every so often.
Drugs Used to Treat Paroxysmal Supraventricular Tachycardia
The following list of medications are used in the treatment of this particular condition, or somehow associated with.
| Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
|---|---|---|---|---|---|---|---|
| flecainide | Rx | C | N | 5 reviews | 10 | ||
Generic name: flecainide systemic Brand name: Tambocor Drug class: group I Anti-arrhythmics For customers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph, Prescribing Information | |||||||
| Tambocor | Rx | C | N | Insert inspection | 0.0 | ||
Generic name: flecainide systemic Drug class: group I Anti-arrhythmics For customers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
Legend
| Rx | Prescription Only |
|---|---|
| OTC | Over the Counter |
| Rx/OTC | Prescription or Over The Counter |
| Away Tag | This drug might not be approved by the FDA for treating the particular condition. |
| Pregnancy Category | |
|---|---|
| A | sufficient and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (and there is no evidence of risk in later trimesters). |
| B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women. |
| C | Animal reproduction studies have demonstrated an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| D | there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may warrant used in pregnant women despite potential risks. |
| X | Studies in animals or humans have demonstrated fetal abnormalities and/or there`s positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with used in pregnant women clearly outweigh potential benefits. |
| N | FDA have not classified the drug. |
| Controlled Substances Act (CSA) Program | |
|---|---|
| N | isn`t subject to the Controlled Substances Act. |
| 1 | Has a higher possibility of abuse. Has no currently accepted medical use in treatment in the United States. There`s just a lack of accepted safety for use under medical supervision. |
| 2 | Has a higher possibility of abuse. Includes a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may lead to severe emotional or physical dependence. |
| 3 | Has a possibility for abuse less than people in schedules 1 and 2 2. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
| 4 | Has a minimal potential for abuse relative to people in program 3. It has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to people in program 3. |
| 5 | Has a minimal potential for abuse relative to people in program 4. Includes a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to people in program 4. |
| Alcohol | |
|---|---|
| X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- that I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further advice
Always ask your physician to make sure the information displayed on this page applies to your circumstances.
- Painful Coitus (Female)
- Painful Intercourse
- Pancreatic Exocrine Dysfunction
- Pancreatic Secretion
- Pancreatogenic Diabetes
- PANDAS Syndrome
- Panhypopituitarism
- Panuveitis
- Papilledema Associated with Increased Intracranial Pressure
- Papilledema Associated with Retinal Disorder
- Paracoccidioidomycosis
- Paradoxical Vocal Cord Dysfunction (PVCD)
- Paradoxical Vocal Cord Motion Disorder (PVCM)
- Paragonimus Westermani, Lung Fluke
- Paralytic Disorder
- Paraphimosis
- Paraplegia
- Parathyroid Cancer
- Parotid Tumors
- Paroxysmal Atrial Tachycardia
- Paroxysmal Junctional Tachycardia
- Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Supraventricular Tachycardia
- Parsonage Turner Syndrome
- Patency Maintenance of Indwelling Intravenous Devices
- Pathological Hypersecretory Conditions
Top USA Pharma Companies
Product Categories
Popular Categories
Health Condition
- Painful Coitus (Female)
- Painful Intercourse
- Pancreatic Exocrine Dysfunction
- Pancreatic Secretion
- Pancreatogenic Diabetes
- PANDAS Syndrome
- Panhypopituitarism
- Panuveitis
- Papilledema Associated with Increased Intracranial Pressure
- Papilledema Associated with Retinal Disorder
- Paracoccidioidomycosis
- Paradoxical Vocal Cord Dysfunction (PVCD)
- Paradoxical Vocal Cord Motion Disorder (PVCM)
- Paragonimus Westermani, Lung Fluke
- Paralytic Disorder
- Paraphimosis
- Paraplegia
- Parathyroid Cancer
- Parotid Tumors
- Paroxysmal Atrial Tachycardia
- Paroxysmal Junctional Tachycardia
- Paroxysmal Nocturnal Hemoglobinuria
- Paroxysmal Supraventricular Tachycardia
- Parsonage Turner Syndrome
- Patency Maintenance of Indwelling Intravenous Devices
- Pathological Hypersecretory Conditions
Easily find an affordable health insurance plan
